Dynamic

11C-methionine PET-CT dynamic acquisition glioma prognosis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Sep 2021
Historique:
received: 30 07 2021
revised: 19 08 2021
accepted: 10 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 14 10 2021
Statut: epublish

Résumé

The prognostic evaluation of glioma recurrence patients is important in the therapeutic management. We investigated the prognostic value of Sixty-seven consecutive patients who underwent MET-PET for suspected glioma recurrence at MR were retrospectively included. Twenty-one patients underwent static MET-PET; 46/67 underwent dynamic MET-PET. In all patients, SUVmax, SUVmean and tumour-to-background ratio (T/B) were calculated. From dynamic acquisition, the shape and slope of time-activity curves, time-to-peak and its SUVmax (SUVmax The overall median follow-up was 19 months from MET-PET. Recurrence patients (38/67) had higher SUVmax ( Semiquantitative parameters and SUVmax

Identifiants

pubmed: 34638262
pii: cancers13194777
doi: 10.3390/cancers13194777
pmc: PMC8508090
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
J Neurooncol. 2017 Apr;132(2):277-286
pubmed: 28102485
AJNR Am J Neuroradiol. 2018 Sep;39(9):1629-1634
pubmed: 29954817
Expert Rev Anticancer Ther. 2010 May;10(5):609-13
pubmed: 20469990
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1486-1495
pubmed: 32034446
Q J Nucl Med Mol Imaging. 2018 Sep;62(3):254-266
pubmed: 29696948
Neurosurg Rev. 2017 Apr;40(2):223-229
pubmed: 27282449
Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2082-7
pubmed: 17763978
Neurology. 2015 Feb 17;84(7):710-9
pubmed: 25609769
J Neurooncol. 2017 Sep;134(3):495-504
pubmed: 28382534
J Neurooncol. 2009 Jun;93(2):233-41
pubmed: 19099197
PLoS One. 2019 Oct 11;14(10):e0222717
pubmed: 31603915
J Neurosurg. 2001 Nov;95(5):746-50
pubmed: 11702862
Oncotarget. 2017 Jul 5;8(53):91030-91039
pubmed: 29207622
World Neurosurg. 2018 Jun;114:e1211-e1224
pubmed: 29625311
Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):176-82
pubmed: 11926379
J Cereb Blood Flow Metab. 1990 Sep;10(5):698-706
pubmed: 2384542
Neuro Oncol. 2014 Apr;16(4):603-9
pubmed: 24305722
Brain Tumor Pathol. 2015 Oct;32(4):253-60
pubmed: 25812514
Neuro Oncol. 2018 Feb 19;20(3):411-419
pubmed: 29016947
J Neurooncol. 2018 Jul;138(3):649-658
pubmed: 29564749
Cancers (Basel). 2021 Apr 26;13(9):
pubmed: 33926002
Clin Transl Oncol. 2014 Sep;16(9):770-5
pubmed: 24647843
Cancers (Basel). 2021 May 12;13(10):
pubmed: 34066294
Clin Nucl Med. 2011 Oct;36(10):841-7
pubmed: 21892031
J Neurooncol. 2016 Nov;130(2):269-282
pubmed: 27174197
Clin Nucl Med. 2019 Mar;44(3):186-193
pubmed: 30562194
Acta Neurochir (Wien). 2019 Aug;161(8):1723-1732
pubmed: 31254065
Ann Nucl Med. 2005 Dec;19(8):677-83
pubmed: 16444993
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1025-35
pubmed: 23525498
Semin Nucl Med. 2017 Jan;47(1):5-17
pubmed: 27987557
Neuro Oncol. 2013 Mar;15(3):341-51
pubmed: 23335162
Radiat Oncol. 2014 Dec 21;9:299
pubmed: 25529015
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
J Neurooncol. 2017 Dec;135(3):621-627
pubmed: 28956223
J Cancer. 2019 Apr 5;10(7):1707-1716
pubmed: 31205526
EJNMMI Res. 2020 May 29;10(1):56
pubmed: 32472232
Lancet Oncol. 2017 Jun;18(6):e315-e329
pubmed: 28483413
J Neurosurg. 2014 Nov;121(5):1115-23
pubmed: 25192475
Neuro Oncol. 2008 Apr;10(2):162-70
pubmed: 18356283
JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6):569-78
pubmed: 1494216
J Comput Assist Tomogr. 1987 Mar-Apr;11(2):208-13
pubmed: 3493274
J Neurooncol. 1986;3(4):397-404
pubmed: 3485705
Trends Pharmacol Sci. 2009 Aug;30(8):431-40
pubmed: 19616318
AJNR Am J Neuroradiol. 2016 Jan;37(1):44-50
pubmed: 26381556
Acta Radiol. 1987 Sep-Oct;28(5):505-9
pubmed: 2960339
Mol Imaging. 2012 Nov-Dec;11(6):516-27
pubmed: 23084252
AJNR Am J Neuroradiol. 2008 Jun;29(6):1176-82
pubmed: 18388218
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
J Nucl Med. 2014 Feb;55(2):198-203
pubmed: 24379223
Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):868-73
pubmed: 12692687
Neuro Oncol. 2011 Aug;13(8):806-19
pubmed: 21757446
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
J Neurooncol. 2012 Aug;109(1):115-22
pubmed: 22528799
Nuklearmedizin. 2011;50(4):167-73
pubmed: 21789338
Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):39-51
pubmed: 15309329
Int J Mol Sci. 2019 Sep 20;20(19):
pubmed: 31547109
Neurosurgery. 1989 Nov;25(5):720-8
pubmed: 2586726
Cancer. 2001 Sep 15;92(6):1541-9
pubmed: 11745233

Auteurs

Maria Vittoria Mattoli (MV)

Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti, 66100 Chieti, Italy.

Gianluca Trevisi (G)

Neurosurgical Unit, Presidio Ospedaliero Santo Spirito, 65124 Pescara, Italy.

Valentina Scolozzi (V)

UOC di Medicina Nucleare, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Amedeo Capotosti (A)

Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Fabrizio Cocciolillo (F)

UOC di Medicina Nucleare, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Irene Marini (I)

Nuclear Medicine and Radiometabolic Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Valerio Mare (V)

Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Luca Indovina (L)

Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Massimo Caulo (M)

Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti, 66100 Chieti, Italy.
Department of Radiology, University "G. d'Annunzio" of Chieti, 66100 Chieti, Italy.

Antonella Saponiero (A)

UOSD di Oncologia, Dipartimento di Oncologia, Presidio Cassia-S. Andrea-ASL RM1, 00100 Rome, Italy.

Mario Balducci (M)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Silvia Taralli (S)

UOC di Medicina Nucleare, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.

Maria Lucia Calcagni (ML)

UOC di Medicina Nucleare, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy.
Dipartimento Universitario di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.

Classifications MeSH